Algorae Pharmaceuticals Limited (ASX:1AI)
Australia · Delayed Price · Currency is AUD 0.0130
0.00 (0.00%)
May 8, 2026, 2:22 PM AEST
Algorae Pharmaceuticals Market Cap
Algorae Pharmaceuticals has a market cap or net worth of 26.3 million as of May 8, 2026. Its market cap has increased by 159.77% in one year.
Market Cap
26.30M
Enterprise Value
24.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since September 1, 2004, Algorae Pharmaceuticals's market cap has increased from 12.17M to 26.30M, an increase of 116.14%. That is a compound annual growth rate of 3.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 26.30M | 11.24% |
| Dec 31, 2025 | 23.64M | 133.52% |
| Dec 30, 2024 | 10.12M | -39.06% |
| Dec 29, 2023 | 16.61M | 7.70% |
| Dec 30, 2022 | 15.42M | 185.23% |
| Dec 30, 2021 | 5.41M | -32.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurizon Therapeutics | 56.40M |
| Avecho Biotechnology | 47.76M |
| Imugene | 42.35M |
| NeuroScientific Biopharmaceuticals | 33.26M |
| EZZ Life Science Holdings | 29.42M |
| Proteomics International Laboratories | 28.91M |
| Argenica Therapeutics | 22.48M |
| Noxopharm | 21.51M |